Valsartan and Hydrochlorothiazide
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
68180-101 -
Application number
ANDA078946 -
SPL ID
537df828-cd82-4b5e-9d0d-da8bd1cfd736 -
SPL set ID
d74a85de-5917-401a-b92d-6a95da5d30a6 -
UNII
0J48LPH2TH -
UNII
80M03YXJ7I -
RxCUI
200284 -
RxCUI
200285 -
RxCUI
349353 -
RxCUI
636042 -
RxCUI
636045
What the source publishes
- Labeler
- Lupin Pharmaceuticals, Inc.
- Active ingredients
- Valsartan and Hydrochlorothiazide
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Valsartan and Hydrochlorothiazide",
"splId": "537df828-cd82-4b5e-9d0d-da8bd1cfd736",
"labels": [
{
"setId": "d74a85de-5917-401a-b92d-6a95da5d30a6",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d74a85de-5917-401a-b92d-6a95da5d30a6",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d74a85de-5917-401a-b92d-6a95da5d30a6"
}
],
"routes": [
"ORAL"
],
"labeler": "Lupin Pharmaceuticals, Inc.",
"finished": true,
"packaging": [],
"productId": "68180-101_537df828-cd82-4b5e-9d0d-da8bd1cfd736",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "68180-101",
"deaSchedule": null,
"genericName": "Valsartan and Hydrochlorothiazide",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "HYDROCHLOROTHIAZIDE",
"strength": "12.5 mg/1"
},
{
"name": "VALSARTAN",
"strength": "320 mg/1"
}
],
"applicationNumber": "ANDA078946",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20130321",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175359",
"N0000175419",
"M0471776",
"N0000000070",
"N0000175561"
],
"upc": [
"0368180105091",
"0368180103097",
"0368180104094"
],
"unii": [
"0J48LPH2TH",
"80M03YXJ7I"
],
"rxcui": [
"200284",
"200285",
"349353",
"636042",
"636045"
],
"spl_set_id": [
"d74a85de-5917-401a-b92d-6a95da5d30a6"
],
"pharm_class_cs": [
"Thiazides [CS]"
],
"pharm_class_pe": [
"Increased Diuresis [PE]"
],
"pharm_class_epc": [
"Thiazide Diuretic [EPC]",
"Angiotensin 2 Receptor Blocker [EPC]"
],
"pharm_class_moa": [
"Angiotensin 2 Receptor Antagonists [MoA]"
],
"manufacturer_name": [
"Lupin Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:68180-101_537df828-cd82-4b5e-9d0d-da8bd1cfd736"